Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals's GHG Emissions Data Preview
In 2024, Vertex Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Vertex Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data.  c | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Vertex Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Vertex Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into Vertex Pharmaceuticals's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Vertex Pharmaceuticals amounted to 12,906 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Vertex Pharmaceuticals decreased by 43.19%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a b
Vertex Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Vertex Pharmaceuticals's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Vertex Pharmaceuticals were 8,976 metric tons of CO₂ equivalent (tCO₂e). a
Has Vertex Pharmaceuticals reduced its Scope 1 emissions over time?
Since 2018, Vertex Pharmaceuticals's Scope 1 emissions have increased by 58.47%, reflecting a rising long-term trend in Scope 1 emissions over time. a d
Compared to the previous year (2023), Vertex Pharmaceuticals's Scope 1 emissions increased by 8%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Vertex Pharmaceuticals's Scope 2 emissions?
In 2024, Vertex Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 3,930 tCO₂e using the market-based method. a
Has Vertex Pharmaceuticals reduced its Scope 2 emissions over time?
Since 2018, Vertex Pharmaceuticals's Scope 2 greenhouse gas (GHG) emissions ( Market-Based) have decreased by 63.9%, reflecting a declining long-term trend in Scope 2 emissions over time. a d
What methodology does Vertex Pharmaceuticals use for Scope 2 reporting?
In 2024, Vertex Pharmaceuticals reported its Scope 2 emissions using the market-based method. a
Vertex Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Vertex Pharmaceuticals's Value Chain Emissions
In 2024, Vertex Pharmaceuticals reported 551,647 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Vertex Pharmaceuticals includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Vertex Pharmaceuticals's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Vertex Pharmaceuticals's Scope 3 emissions?
In 2024, Vertex Pharmaceuticals reported total Scope 3 emissions of 551,647 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2023), Vertex Pharmaceuticals's Scope 3 emissions increased by 16.35%, suggesting that the company faced challenges in reducing emissions across its value chain. a
Insights into Vertex Pharmaceuticals’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Vertex Pharmaceuticals reported Scope 1 greenhouse gas (GHG) emissions of 8,976 tCO₂e and total revenues of USD 11,020 millions. This translates into an emissions intensity of 0.81 tCO₂e per millions USD. a
Vertex Pharmaceuticals's Scope 1 Emissions Intensity Compared to Peers
How does Vertex Pharmaceuticals's GHG emissions intensity compare to its peers?
In 2024, Vertex Pharmaceuticals reported a Scope 1 emissions intensity of 0.81 tCO₂e per millions USD. Compared to the peer group median of 4.56 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Vertex Pharmaceuticals rank on GHG emissions intensity within its industry?
In 2024, Vertex Pharmaceuticals ranked 1 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Vertex Pharmaceuticals among the top performers, with one of the lowest emissions intensities relative to peers. a
Insights into Vertex Pharmaceuticals's Total Carbon Footprint
In 2024, Vertex Pharmaceuticals reported a total carbon footprint of 564,553 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 13.63% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a b
The largest contributor to Vertex Pharmaceuticals's total carbon footprint was Scope 3 emissions, accounting for 97.71% of the company's total carbon footprint, followed by Scope 1 emissions at 1.59%. a